Poppy for Medicine projects: lost-cost, high impact economic development initiatives
Building on the
June 2007 release of ICOS’s
Poppy for Medicine project
model, this Economic Case Study provides detailed information on the economics of
producing morphine in small medicine factories in Afghan communities, through Poppy
for Medicine projects. Small morphine producing factories, located in Afghan district
centres, would be able to inexpensively manufacture morphine for sale at prices
significantly below the current retail price for morphine in many countries. With a
nominal start-up cost, a small medicine factory would not only provide jobs and secure
incomes for hundreds of Afghans; it would trigger economic growth and diversification
in the regions within which the
Poppy for Medicine projects are located.
Local medicine factories enhance security of Poppy for Medicine projects
An important security feature of the
Poppy for Medicine project model is the local
transformation of raw poppy materials into morphine medicines immediately after the
harvest period. This Case Study is based on a model scenario in which a medicine
factory has the capacity to process into morphine three metric tons of raw poppy
materials - the quantity that could be produced by ten model
Poppy for Medicine project
communities, each with twenty small farms of less than 0.4 hectares – within the two
month period following the poppy crop harvest.
Diversifying Afghanistan’s economy: extending the Poppy for Medicine project model
Under the
Poppy for Medicine project model, the manufacture of morphine medicines
will occupy less than a quarter of a factory’s operational time each year, leaving the
factories available to add value to other agricultural products cultivated in the region
throughout the rest of the year. Initial research suggests that it may be possible to
extend the
Poppy for Medicine project model to produce other plant-based medicines
suited to the Afghan context, such as the malaria medicine Artemisinin.
Local production of affordable malaria medicines
The production of malaria medicines would be particularly suitable in the context of
Poppy for Medicine projects, as the crop cycle of artemisia, the plant from which
Artemisinin is extracted, is complementary to the poppy crop cycle. In addition, as with
morphine, there is an extensive global need for affordable supplies of malaria medicines
that Afghan medicine production projects could help to meet.